Although these are the only two reports ofPCSK9 inhibitors-induced renal injury, the potential for nephrotoxicity needs tobe monitored when considering PCSK9 inhibitors as an alternative innon-rhabdomyolysis-induced AKI. Here, PCSK9 is linked to acute kidney injury.